[go: up one dir, main page]

WO2009074853A3 - Composition ophtalmique comprenant de la phényléphrine - Google Patents

Composition ophtalmique comprenant de la phényléphrine Download PDF

Info

Publication number
WO2009074853A3
WO2009074853A3 PCT/IB2008/002647 IB2008002647W WO2009074853A3 WO 2009074853 A3 WO2009074853 A3 WO 2009074853A3 IB 2008002647 W IB2008002647 W IB 2008002647W WO 2009074853 A3 WO2009074853 A3 WO 2009074853A3
Authority
WO
WIPO (PCT)
Prior art keywords
ophthalmic composition
phenylephrine
composition
preparing
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/002647
Other languages
English (en)
Other versions
WO2009074853A2 (fr
Inventor
Honey Bala
Rahul Hasija
Sateesh Kumar Chauhan
Deepak Bahri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROMED RESEARCH CENTRE
PROMED RES CT
Original Assignee
PROMED RESEARCH CENTRE
PROMED RES CT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40755940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2009074853(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PROMED RESEARCH CENTRE, PROMED RES CT filed Critical PROMED RESEARCH CENTRE
Publication of WO2009074853A2 publication Critical patent/WO2009074853A2/fr
Publication of WO2009074853A3 publication Critical patent/WO2009074853A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention se réfère à une composition ophtalmique stable et efficace pour application topique qui comprend un agent mydriatique et un polymère viscoélastique, et à des procédés de préparation d'une telle composition destinée à une usage humain et vétérinaire.
PCT/IB2008/002647 2007-12-10 2008-10-07 Composition ophtalmique comprenant de la phényléphrine Ceased WO2009074853A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2583DE2007 2007-12-10
IN2583/DEL/2007 2007-12-10

Publications (2)

Publication Number Publication Date
WO2009074853A2 WO2009074853A2 (fr) 2009-06-18
WO2009074853A3 true WO2009074853A3 (fr) 2009-08-06

Family

ID=40755940

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/002647 Ceased WO2009074853A2 (fr) 2007-12-10 2008-10-07 Composition ophtalmique comprenant de la phényléphrine

Country Status (2)

Country Link
RU (1) RU2600863C2 (fr)
WO (1) WO2009074853A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT511164A1 (de) * 2011-03-03 2012-09-15 Croma Pharma Gmbh Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
CN103491944A (zh) * 2011-04-22 2014-01-01 爱尔康研究有限公司 具有包含两种不同粘度增强剂的粘度增强体系的眼用组合物
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US8859623B1 (en) * 2013-11-14 2014-10-14 Paragon BioTeck, Inc. Methods and compositions of stable phenylephrine formulations
FR3095592B1 (fr) * 2019-05-02 2021-05-21 Unither Pharmaceuticals Composition à base de gomme gellane et de phényléphrine, procédé de fabrication et utilisation comme produit ophtalmique
WO2021150747A1 (fr) * 2020-01-22 2021-07-29 Nevakar Inc. Compositions et récipients de chlorhydrate de phényléphrine

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
WO2002024116A1 (fr) * 2000-09-20 2002-03-28 Shahinian, Lee, Jr. Préparations et médications nasales, inhalables et ophtalmiques locales à conservation spontanée
EP1283043A1 (fr) * 2000-05-17 2003-02-12 Senju Pharmaceutical Co., Ltd. Composition ophtalmique
US20030203034A1 (en) * 2002-04-26 2003-10-30 Allergan Sales, Inc. Compositions for treating hyperemia
US20060110331A1 (en) * 2004-11-24 2006-05-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2007127333A2 (fr) * 2006-04-26 2007-11-08 Aciex, Inc. Compositions pour le traitement et la prévention du gonflement des paupières
US20080050335A1 (en) * 2006-07-25 2008-02-28 Osmotica Corp. Ophthalmic Solutions
WO2008026756A1 (fr) * 2006-08-28 2008-03-06 Senju Pharmaceutical Co., Ltd. Préparation ophtalmique du type à absorption par voie percutanée

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153234C (fr) * 1993-04-16 1999-02-16 Masanobu Takeuchi Composition medicamenteuse aqueuse ayant la propriete de former un gel de maniere reversible
EP0732913B1 (fr) * 1993-04-30 2003-02-26 Nestle S.A. MATIERE VISCOELASTIQUE SYNTHETIQUE DESTINE A DES APPLICATIONS physiologiques tels que DES APPLICATIONS OPHTALMIQUEs
ES2341789T3 (es) * 2004-10-25 2010-06-28 BAUSCH & LOMB INCORPORATED Composiciones oftalmicas y metodos de uso de las mismas.
RU2284181C2 (ru) * 2004-11-11 2006-09-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Федерального агентства по здравоохранению и социальному развитию (ФГУ "МНТК"МГ"им. акад. С.Н. Федорова Росздрава") Фармацевтическая композиция для профилактики инфекции в офтальмологии "интрависк"

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
EP1283043A1 (fr) * 2000-05-17 2003-02-12 Senju Pharmaceutical Co., Ltd. Composition ophtalmique
WO2002024116A1 (fr) * 2000-09-20 2002-03-28 Shahinian, Lee, Jr. Préparations et médications nasales, inhalables et ophtalmiques locales à conservation spontanée
US20030203034A1 (en) * 2002-04-26 2003-10-30 Allergan Sales, Inc. Compositions for treating hyperemia
US20060110331A1 (en) * 2004-11-24 2006-05-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2007127333A2 (fr) * 2006-04-26 2007-11-08 Aciex, Inc. Compositions pour le traitement et la prévention du gonflement des paupières
US20080050335A1 (en) * 2006-07-25 2008-02-28 Osmotica Corp. Ophthalmic Solutions
WO2008026756A1 (fr) * 2006-08-28 2008-03-06 Senju Pharmaceutical Co., Ltd. Préparation ophtalmique du type à absorption par voie percutanée

Also Published As

Publication number Publication date
WO2009074853A2 (fr) 2009-06-18
RU2010128222A (ru) 2012-01-20
RU2600863C2 (ru) 2016-10-27

Similar Documents

Publication Publication Date Title
WO2011014850A3 (fr) Formulations à usage topique à base d'un eutectique
WO2009102467A3 (fr) Dispositifs, formulations et méthodes d’administration de plusieurs agents bénéfiques
WO2010021607A3 (fr) Préparation pharmaceutique
WO2007077561A3 (fr) Compositions et procédés permettant d'améliorer le captage in-vivo d'agents pharmaceutiques
WO2007002597A3 (fr) Formulations a liberation modifiee d'un sel de bupropion
WO2006099169A3 (fr) Nouvelles compositions de liposomes
WO2012040623A3 (fr) Gels nanostructurés capables de libération contrôlée d'agents encapsulés
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
WO2009061431A3 (fr) Compositions pour le traitement et la prévention du gonflement des paupières
WO2011053792A3 (fr) Méthodes et compositions pour une libération prolongée de médicaments
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2007127333A3 (fr) Compositions pour le traitement et la prévention du gonflement des paupières
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
WO2007093880A3 (fr) Nouveaux dérivés d'indolopyrone et leur procédé de préparation
WO2009071689A3 (fr) Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine
WO2008006795A3 (fr) Composés d'indole
WO2009074853A3 (fr) Composition ophtalmique comprenant de la phényléphrine
WO2008136034A3 (fr) Compositions ophtalmiques pour le traitement d'une hypertension oculaire et d'un glaucome
WO2006138735A3 (fr) Compositions de gel pour administration topique
WO2007090661A3 (fr) Combinaison de substances actives
WO2009032843A3 (fr) Aminoalcools substitués
WO2009001099A3 (fr) Composition pharmaceutique
WO2007133944A3 (fr) Administration topique d'acyclovir

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08858901

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010128222

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 08858901

Country of ref document: EP

Kind code of ref document: A2